Managers
PyroGenesis Canada, a clean-tech company that designs, develops, manufactures and commercialises plasma waste-to-energy systems and plasma torch products, has signed two additional military contracts totalling approximately USD1.2 million (CAD1.6 million).
As of 30 June 2016, total military contracts signed now exceed USD3.7 million (CAD5 million).
The military contracts are all expected to be completed by the end of Q2 2017.
"Since 30 June 2016, both military contracts and non-military contracts now exceed CAD13 million, the majority of which will be completed this year," says P Peter Pascali, president and CEO of PyroGenesis. "This coupled with the Company's success
Private equity firm Calera Capital has acquired a majority stake in Carnegie Fabrics, a family-owned supplier and innovator of sustainable textiles and wallcoverings for the corporate, healthcare, hospitality and education building markets.
Cliff Goldman, Carnegie’s president, will retain a significant equity interest in the business. Terms of the transaction have not been disclosed.
Mark Williamson, managing partner of Calera Capital, says: “Carnegie has a long and successful track record of providing high-performance interior textiles to the architecture and design community and their clients. As a leading independent firm with a proven history of product innovation, there remain significant opportunities
Mid-market advisory firm Clearwater International completed a record breaking 106 deals worth over EUR9 billion in 2016 – a deal value increase of over 120 per cent from 2015.
Average deal values also nearly doubled during the period.
In a year where the business completed mergers with firms in both France and Germany, all territories, sectors and service lines experienced exceptional levels of M&A activity.
For the third year running, the industrials and chemicals team was the most active in deal completions including the merger of X-label with RAKO and Baumgaten – a cross border deal which created
Private equity fund manager and Enterprise Investment Scheme (EIS) and venture capital trust (VCT) specialist Calculus Capital has invested GBP3 million in Origin Broadband, a provider of internet and phone services.
Since launch in 2011, Origin has developed its own infrastructure and now has the sixth largest broadband network in the UK based on premises passed.
The investment by Calculus will allow Origin to hire new staff and will be primarily used to expand its sales team to develop new business across the UK.
John Glencross, chief executive of Calculus Capital, says: “The continuing migration of UK households to
Influencer marketing platform Buzzoole has raised USD830,000 through a convertible note funding, led by international venture fund Impulse VC with co-investment from Swiss technology venture firm R301 Capital.
The investment has potential to double within 18 months (up to USD1.6 million) and draw further investors.
Buzzoole’s proprietary, big data-based algorithm works to connect brands to the right influencers. It has almost 200,000 influencers on its platform, defined by criteria beyond follower count. The platform’s international influencer base provides brands with a way to start conversations, reach new audiences and boost their promotional campaigns.
Founded in 2013 in Naples,
Seedrs, the investment platform backed by Neil Woodford, saw more than GBP85 million invested into campaigns on the platform and 159 deals funded in 2016.
The British fintech company has been live for four-and-a-half years and recently surpassed GBP190 million invested into campaigns with more than 450 deals funded since its launch.
October marked the platform’s biggest ever month with almost GBP20 million invested into campaigns, GBP4.35 million of which was invested into employee and customer engagement provider, Perkbox, becoming Seedrs’ biggest fundraise since launch.
In the same month almost 3,000 Seedrs investors backed peer-to-peer travel money platform,
Omnes Capital is selling its stake in DenyAll to cybersecurity specialist Rohde & Schwarz Cybersecurity.
Omnes Capital has been shareholder in the company alongside Truffle Capital for many years.
It played an active role in its consolidation strategy, which was made concrete with the successive acquisitions of VulnIT in 2012 and BeeWare in 2014.
More particularly, Omnes Capital has encouraged DenyAll’s international expansion. The company has been able to develop its operations in over 30 countries.
DenyAll shares with Rohde & Schwarz Cybersecurity the ambition of creating a European market leader in cybersecurity with an international presence.
Edison Advisors, the investor relations and consulting arm of the Edison Group, has launched a full-service investor relations business to give private and public companies access to its team of analysts and pools of investment capital through its global investor networks.
Established 15 years ago, Edison Investment Research has a team of 80 research analysts producing research across all sectors.
Edison has developed an intelligent distribution platform with analytics capability to identify global investment trends and market dynamics, which it has now evolved for the benefit of investor relations clients.
Rachel Carroll (pictured), global head of investor relations
Tikehau Capital has filed a tender offer with the Autorité des Marchés Financiers (AMF) for the securities of Salvepar, a listed company that focuses on minority investments in listed and non-listed companies.
Tikehau Capital has also initiated a project to reorganise its shareholding structure and governance, as well as those of its consolidated subsidiaries, branches and interests as a whole, in order to prepare for a new phase of development.
As part of this project, Tikehau Capital, which holds 58.8 per cent of the share capital and 59.8 per cent of the voting rights of Salvepar, is filing a
Founded to facilitate access to drugs in development for physicians and their patients, myTomorrows has closed a EUR10 million growth funding round co-led by EQT Ventures and Octopus Ventures, with participation from existing investors Balderton Capital and Sofinnova Partners.
Former GlaxoSmithKline chief medical officer James Shannon has also been appointed chairman of the supervisory board.
Currently active in 17 countries, myTomorrows saw there was a problem that needed solving in the way physicians and their patients could access investigational drugs rendering potentially life-saving drugs out of reach. By applying technologies, myTomorrows has built a platform for doctors and patients
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
